Lin BioScience, Inc.(TW:6696)
NT$166.50+3.50 (+2.15%)
TW:6696
Lin BioScience, Inc. financials statements
NT$166.50
At close:+3.50 (+2.15%)
Lin BioScience, Inc. (6696) Income Statement
Lin BioScience, Inc. Income Statement
Last quarter (Q2 2026), Lin BioScience, Inc.'s total revenue was NT$0.00. In Q2, Lin BioScience, Inc.'s net income was NT$-872.63M. See Lin BioScience, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | NT$ 0.00 | |
| NT$ -23.79M | NT$ -20.21M | NT$ -17.93M | NT$ -11.16M | NT$ -4.39M | |
| NT$ 2.83B | NT$ 1.46B | NT$ 1.10B | NT$ 445.13M | NT$ 338.28M | |
| Depreciation and Amortization | NT$ 23.79M | NT$ 20.21M | NT$ 17.93M | NT$ 11.16M | NT$ 4.39M |
| NT$ -2.61B | NT$ -1.44B | NT$ -1.07B | NT$ -465.84M | NT$ -485.95M | |
| NT$ -2.86B | NT$ -1.46B | NT$ -1.10B | NT$ -445.13M | NT$ -338.28M | |
| NT$ 220.14M | NT$ 129.35M | NT$ 6.29M | NT$ -32.74M | NT$ -152.14M | |
| NT$ -2.64B | NT$ -1.33B | NT$ -1.09B | NT$ -477.87M | NT$ -490.41M | |
| NT$ -1.36B | NT$ -744.27M | NT$ -687.19M | NT$ -313.52M | NT$ -434.70M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -16.73 | NT$ -9.47 | NT$ -9.23 | NT$ -4.37 | NT$ -6.23 |
| Diluted EPS | NT$ -16.73 | NT$ -9.47 | NT$ -9.23 | NT$ -4.37 | NT$ -6.23 |
| Weighted Average Shares Outstanding | 81.47M | 78.60M | 74.48M | 71.73M | 69.80M |
| Weighted Average Shares Outstanding (Diluted) | 81.47M | 78.60M | 74.48M | 71.73M | 69.80M |
Currency in TWD

